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Abstract
Introduction: This study compared the effects of hydroxyethyl starch 130/0.4, hydroxyethyl starch 200/0.5, and
succinylated gelatin on oxidative stress and the inflammatory response in a rodent hemorrhagic shock model.
Methods: Sodium pentobarbital-anesthetized adult male Wistar rats (200 g to 220 g) were subjected to a severe
volume-controlled hemorrhage using arterial blood withdrawal (30 mL/kg to 33 mL/kg) and resuscitated with a
colloid solution at the same volume as blood withdrawal (hydroxyethyl starch 130/0.4, hydroxyethyl starch 200/0.5,
or succinylated gelatin). Arterial blood gas parameters were monitored. Malondialdehyde (MDA) content and
myeloperoxidase (MPO) activity in the liver, lungs, intestine, and brain were measured two hours after resuscitation.
The levels of tumor necrosis factor-alpha (TNF-a) and interleukin-6 in the intestine were also measured.
Results: Infusions of hydroxyethyl starch 130/0.4, but not hydroxyethyl starch 200/0.5 or succinylated gelatin,
significantly reduced MDA levels and MPO activity in the liver, intestine, lungs and brain, and it also inhibited the
production of TNF-a in the intestine two hours after resuscitation. However, no significant difference between
hydroxyethyl starch 200/0.5 and succinylated gelatin was observed.
Conclusions: Hydroxyethyl starch 130/0.4, but not hydroxyethyl starch 200/0.5 or succinylated gelatin, treatment
after hemorrhagic shock ameliorated oxidative stress and the inflammatory response in this rat model. No
significant differences were observed after hydroxyethyl starch 200/0.5 or succinylated gelatin administration at
doses of approximately 33 mL/kg.
Keywords: Hemorrhagic shock, Fluid resuscitation, Multiple organ failure, Hydroxyethyl starch, Oxidative stress,
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Introduction
Hemorrhagic shock (HS) is the leading cause of death in
civilian and military trauma [1,2]. Initial survivors of HS
are particularly susceptible to the systemic inflammatory
response syndrome (SIRS), which triggers multiple
organ failure (MOF) and post-traumatic death [3-5]. The
pathogenesis of multiple organ failure remains elusive,
but the oxidative stress and systemic inflammation that
are induced by hemorrhagic shock/fluid resuscitation
(HS/R) contribute to the occurrence of MOF [6,7].
Fluid resuscitation is a common intervention for the
management of HS victims to maintain organ perfusion,
particularly on the battlefield. However, fluid resuscita-
tion may contribute to oxidative stress and inflammation
due to reperfusion injury. Oxidative stress induced by
reactive oxygen species (ROS) may directly damage cellu-
lar membranes via lipid peroxidation. Oxidative stress
also initiates systemic inflammatory cascades through the
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enhancement of neutrophil activation [8]. Activated neu-
trophils release cytotoxic ROS, proteases and elastases
which produce tissue injury, an enhanced systemic
inflammatory response and MOF [9,10]. Therefore, ideal
resuscitation strategies should suppress oxidative stress
and the systemic inflammatory response after HS in addi-
tion to maintaining effective organ perfusion. Colloid
solutions are widely used for the prevention and correc-
tion of hypovolemia in clinical fluid management. How-
ever, direct comparisons of oxidative stress and the
inflammatory response after commonly used synthetic
colloid infusions in hemorrhagic shock are lacking.
Our understanding of the important role of resuscitation
fluids in the pathogenesis of MOF raises questions on the
effect of widely used colloid fluids in the suppression of
oxidative stress and the inflammatory response in vital tis-
sues. We hypothesized that oxidative stress and the inflam-
matory response is influenced by the choice of colloid
solutions. Hydroxyethyl starch (HES), gelatin (GEL), and
dextrans are commonly used synthetic colloids [11,12].
HES 130, HES 200, succinylated GEL, and dextran 70 are
four representative products. The present study in a rat HS
model compared HES 130, HES 200, and GEL to demon-
strate their relative therapeutic benefits in the amelioration
of HS/R-induced oxidative stress and the inflammatory
response. Dextran 70 was not included in this experiment
because it is not tolerated by rats [13,14]. Malondialdehyde
(MDA), which is a product of lipid peroxidation, was mea-
sured to determine the oxidative stress in tissues in this
study. Myeloperoxidase (MPO) activity was measured to
determine neutrophil sequestration in tissues [15]. The
levels of tumor necrosis factor alpha (TNF-a) and interleu-
kin-6 (IL-6) in the intestine were also measured.
Materials and methods
Animals
The ethics committee of the Institute of Transfusion
Medicine, Academy of Military Medical Sciences
approved the study methods. All efforts were made to
minimize the number of animals used and their suffering.
Thirty-one male Wistar rats weighing 200 g to 220 g
(Vital River Laboratories, Beijing, China) were used after
a minimum five- to seven-day acclimation period at 25°C
in a 12-hour light/dark cycle.
Surgical procedures
The rats were anesthetized with intraperitoneal injec-
tions of sodium pentobarbital (50 mg/kg) and allowed
to breathe spontaneously in a supine position on a heat-
ing pad (SOFTRON, TMS-201, Beijing, China) that was
maintained at 37°C ± 0.1°C throughout the study. The
right femoral artery and vein were catheterized with
polyethylene catheters (PE-50). Supplementary doses of
pentobarbital were administered when necessary.
Hemorrhagic shock protocol
A rat HS model was prepared as described previously [16]
with modifications. A volume-controlled hemorrhage of
18 mL/kg (approximately 30% of total blood volume) was
performed for 30 minutes through the right femoral arter-
ial catheter after surgical preparation and 10 minutes of
stabilization. The animals were subjected to a slower
hemorrhage of 12 mL/kg to 15 mL/kg (approximately 20%
to 25% of total blood volume) for 35 minutes (Figure 1).
Hemorrhage was performed using pumps (Softron Beijing,
Inc., Beijing, China). The rats with a base excess (BE) of
-9 mmol/L to -12 mmol/L were resuscitated via the
femoral vein after blood withdrawal.
Resuscitation groups
The animals were randomized into the following four
groups: 1) sham group that underwent all instrumenta-
tion procedures without blood collection (n = 7); 2)
HES 130 group, volume resuscitation with 6% HES 130/
0.4 (Voluven®, Fresenius-Kabi, Bad Homberg, Germany)
(n = 8); 3) HES 200 group, volume resuscitation with
6% HES 200/0.5 (HAES-steril®, Fresenius-Kabi, Bad
Homberg, Germany) (n = 8); and 4) GEL group, resusci-
tation with 4% succinylated GEL (Gelofusine®, B. Braun,
Shenyang, China) (n = 8). The rats were resuscitated
using the same volume of synthetic colloid solutions as the
volume of blood withdrawn. All infusions were performed
using a pump driven at a constant rate of 0.33 mL/minute
over 20 minutes in all groups.
Blood and tissue sampling
Blood gas analysis was performed at baseline, after blood
withdrawal and two hours after resuscitation using
0.25 mL of arterial blood with a blood gas analyzer
(ABL80 FLEX, Radiometer Copenhagen, Denmark). All
of the animals were euthanized by exsanguination under
anesthesia two hours after resuscitation. Tissue samples
were washed with cold saline, snap-frozen in liquid
nitrogen, and stored in liquid nitrogen until assayed.
Measurement of MDA and MPO activity levels
Tissues were homogenized and sonicated on ice in 0.9%
saline. The homogenates were centrifuged at 1,500 g for
15 minutes at 4°C. The supernatants were used for the
measurement of MDA levels and MPO activity (Jian-
cheng Biological Institute, Nanjing, China) using colori-
metric determination according to the manufacturer’s
recommendations.
Measurement of inflammatory cytokines levels
The intestinal levels of TNF-a and IL-6 were deter-
mined using an enzyme-linked immunosorbent assay
(ELISA) kit (PeproTech, Rocky Hill, NJ, USA) according
to the manufacturer’s instructions. Briefly, the intestine
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was homogenized on ice in 0.9% saline containing a
protease inhibitor cocktail (Roche, Mannheim,
Germany). The homogenates were centrifuged at 1,500 g
for 15 minutes at 4°C, and the supernatants were assayed
for TNF-a and IL-6. Values are expressed as pg/mg
protein.
Statistical analysis
Results are expressed as the means±SD. All data were
examined for normal distribution and homogeneity of
variance and analyzed using analysis of variance with
post hoc least significant difference when normality and
homogeneity of variance assumptions were satisfied;
otherwise, the non-parametric Kruskal-Wallis test was
applied. Blood gas variables were studied using the var-
iance analysis test for repeated measurements. P values
<0.05 were considered significant. Data were analyzed
using SPSS Version 18 (SPSS, Chicago, IL, USA).
Results
Blood gas analysis
The pH, pCO2, pO2 and BE values were not different
between groups at baseline (Table 1). No significant dif-
ferences in pH, pCO2, pO2 and BE values were observed
in the groups that underwent hemorrhagic shock at the
end of hemorrhage. pH, pCO2, and BE values and
hemoglobin content decreased significantly at the end of
hemorrhage in hemorrhagic groups, but the pO2 value
increased in these groups (P < 0.05 versus baseline).
Resuscitation increased pH values (P < 0.05 versus base-
line and after hemorrhage). Moreover, the pH value was
higher in the HES 130 group than in the HES 200 and
sham groups (P < 0.05). Infusion of HES 130 and GEL
decreased the pO2 (P < 0.05 versus after hemorrhage),
but the pO2 values were not different among the HS/R
groups. BE values improved at the end of the experi-
ment in the HES 130, HES 200, and GEL groups (P <
0.05 versus after hemorrhage). However, no pronounced
differences were observed among the three groups.
Hemoglobin content exhibited a further decrease when
the animals were resuscitated with fluids (P < 0.05 ver-
sus after hemorrhage).
Tissue lipid peroxidation levels
MDA concentrations in the liver, lungs, intestine and
brain of rats that were resuscitated with HES 130 were
all significantly lower compared to the GEL group (P
0.05; Figure 2). HES 130 significantly suppressed the ele-
vation of MDA levels in the liver, intestine, and brain
compared to HES 200 (P < 0.01), but similar MDA
levels were observed in the lungs. No significant differ-
ences were observed between the HES 200 and GEL
groups in all tissues.
Tissue neutrophil accumulation
MPO activity in the liver, lungs, intestine, and brain in
the HES 130 group was significantly reduced compared
to the HES 200 group (P < 0.05; Figure 3). The infusion
of HES 130 also decreased MPO activity in all measured
tissues compared to the GEL group (P < 0.05). No sig-
nificant difference between the HES 200 and GEL
groups were observed in all four tissues.
Intestinal levels of inflammatory cytokines
The intestinal TNF-a elevation was significantly sup-
pressed in the HES 130 group compared to the HES
200 group (P < 0.05; Figure 4). Intestinal TNF-a was
also lower in the HES 130 group than in the GEL group
(P < 0.05). However, no statistically significant differ-
ences in the TNF-a level were observed between the
HES 200 and GEL groups. The HES 130 group show a
trend for decrease in the IL-6 level compared to the
HES 200 and GEL groups, but there was no statistically
significant difference.
Discussion
The present study demonstrated that HES 130 infusion
suppressed oxidative stress and the inflammatory
response in a rodent model of controlled hemorrhage
compared to HES 200 and GEL. No significant differ-
ences were observed between HES 200 and GEL.
Prolonged organ ischemia due to hemorrhagic shock
may lead to death. Therefore, early aggressive fluid
resuscitation for adequate tissue and cellular perfusion
has been the therapeutic norm in hemorrhagic shock
Figure 1 Design of the hemorrhagic shock protocol.
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patients. However, this notion has been challenged
recently [17]. Laboratory efforts directed toward the dis-
covery of the ideal resuscitative fluid have emerged from
an understanding of hemorrhagic shock as a disease of
decreased perfusion and altered immunity. Therefore,
research efforts aimed at the identification of treatments
for hemorrhagic shock have targeted volume restoration
and the prevention and amelioration of the immune and
inflammatory effects of hemorrhage [18]. Crystalloids
differentially influence hemorrhage-induced oxidative
stress and inflammatory responses through the upregu-
lation of ROS generation and neutrophil activity [10,19].
HES solutions are synthetic colloids that are widely
used to maintain or improve tissue perfusion in HS treat-
ment. However, the pharmacology of HES varies greatly
between solutions depending on their characteristics,
including molecular weight, the degree of hydroxyethyl
substitution and the C2/C6 ratio of hydroxyethylation
[20]. HES 200 and HES 130 solutions are commonly used
HES solutions. Blood loss and transfusion requirements
are significantly reduced in major surgery when HES 130
is administered compared to HES 200 [21,22]. Further-
more, platelet dysfunction exhibits a faster recovery after
the infusion of HES 130 compared to HES 200 [23].
However, little is known about the effects of the two dif-
ferent HES solutions on oxidative stress and the inflam-
matory response following HS/R.
HES 200 decreases the plasma levels of coagulation
factor VIII and von Willebrand factor; this produces
coagulation impairment [21,24] and bleeding events [25]
compared to HES 130. Extensive cross-talk is observed
between inflammation and hemostasis [26]. Vancine et
al. demonstrated that factor VIII deficiency is associated
with higher inflammatory levels after a lipopolysacchar-
ide (LPS) challenge [27]. This result suggests that the
impairment in the blood coagulation system results in a
relatively poor anti-oxidative and anti-inflammatory
effect following HS/R for HES 200. Moreover, the
advantages of HES 130 may be due to improvements in
tissue oxygen [28] due to its hemorheological advantages
over HES 200 [29]. Our results partially confirmed a
previous study. Huter et al. demonstrated that 6% HES
130/0.42, which is another rapidly degradable HES solu-
tion with low molecular weight and degree of substitu-
tion, significantly reduces macrophage infiltration and
interstitial cell proliferation compared to 10% HES 200/
0.5 in an isolated kidney perfusion model [30].
HES 200 exhibits anti-inflammatory effects in vivo and
in vitro [31-34]. In an HS model, a 20 mL/kg HES 200
infusion inhibits the inflammatory response following
HS/R compared to GEL [17]. Tsai et al. demonstrated that
resuscitation using 8 mL/kg HES 200 prevents oxidative
stress and nuclear factor-kappa B (NF-B) activation [35].
HES 200 attenuates cell injury in inflammatory-stimulated
tubular epithelial cells in vitro [31]. However, these results
are not consistent with our observations. We did not
observe any differences in oxidative stress and inflamma-
tory responses between the GEL and HES 200 groups.
Table 1 Arterial blood gas variables for all groups during the experiment
Variables Groups Baseline After hemorrhage Two hours post-resuscitation
pH SHAM 7.41 ± 0.02 - 7.44 ± 0.03a
GEL 7.42 ± 0.02 7.36 ± 0.05a 7.48 ± 0.04ab
HES 200 7.42 ± 0.03 7.34 ± 0.05a 7.46 ± 0.02ab
HES 130 7.42 ± 0.03 7.35 ± 0.03a 7.4 9 ± 0.03abcd
pO2 (Torr) SHAM 74.9 ± 5.3 - 81.0 ± 9.5
GEL 78.5 ± 4.5 109 ± 3.9a 87.7 ± 11.8b
HES 200 78.5 ±8.5 105.2 ± 12.8a 91.1 ± 18.8
HES 130 79.0 ± 6.5 106.5 ± 13.7a 91.0 ± 5.5abc
pCO2 (Torr) SHAM 39.0 ± 3.1 - 36.7 ± 3.7
GEL 39.8 ± 3.6 25.3 ± 3.8a 29.3 ± 4.0ac
HES 200 39.6 ± 3.6 28.9 ± 3.2a 30.7 ± 2.7ac
HES 130 40.2 ± 3.0 28.3 ± 4.4a 28.0 ± 2.7ac
Hemoglobin (g/dl) SHAM 12.4 ± 0.7 - 12.6 ± 0.5
GEL 12.9 ± 1.3 10.0 ± 0.6a 6.8 ± 0.7abc
HES 200 13 ± 0.4 9.7 ± 1.0a 6.7 ± 0.7abc
HES 130 13.4 ± 0.5 9.8 ± 0.5a 7.2 ± 0.7abc
BE (mmol/L) SHAM 0.4 ± 2 - 1.3 ± 1.8
GEL 1.5 ± 1.9 -9.9 ± 2.1a -1.6 ± 2.1abc
HES 200 1.5 ± 1.0 -9.3 ± 2.39a -1.7 ± 1.8abc
HES 130 1.8 ± 1.6 -9.2 ± 2.09a -1.6 ± 2.4abc
aP <0.05 versus baseline, bP <0.05 versus after hemorrhage, cP <0.05 versus the sham group, dP <0.05 versus the HES 200 group. Values are means ± SD. BE, base
excess; pCO2, partial pressure of carbon dioxide; pO2, partial pressure of oxygen.
Chen et al. Critical Care 2013, 17:R141
http://ccforum.com/content/17/4/R141
Page 4 of 9
The infusion dose may account for these controversial
results. Approximately 33 mL/kg of the colloid solutions
were used in this study, which is the recommended maxi-
mum dose for HES 200, but it is far less than the recom-
mended maximum daily dose of HES 130 (50 mL/kg) [36].
Tian et al. demonstrated that a lower dose of HES 200
(3.75 and 7.5 mL/kg) significantly suppresses LPS-induced
NF-B activation in four tissues (lungs, liver, heart, and
kidneys). However, 15 mL/kg HES 200 inhibits NF-B
activity only in the lungs and liver, and 30 mL/kg HES 200
exerts no effect in any measured organs [35,37]. The effect
of GEL on the inflammatory response was similar at three
doses (7.5, 15 and 30 mL/kg) [38]. These results indicate
that the anti-inflammatory effect of HES 200 is volume-
dose dependent. A large infusion dose may inhibit the
anti-inflammatory effects of HES 200, which produces
similar oxidative stress and inflammatory responses
between the GEL and HES 200 groups. Future studies are
required to delineate the underlying mechanism.
The comparison of the impact of HES 130 and GEL
on oxidative stress and the inflammatory response in
hemorrhagic shock demonstrated conclusive protective
effects after the HES 130 infusion. This result is consis-
tent with previous studies in other models [38,39] and
clinical cardiac surgery [40]. HES 130 inhibits the
inflammatory response and NF-B activation in a rat
model of polymicrobial sepsis but GEL does not [38].
Varga et al. demonstrated that HES 130 prevents ische-
mia reperfusion-induced leukocyte reactions compared
to GEL [39]. One or more protective mechanisms may
come into play. Firstly, the animal peptide nature of
GEL may render an enhanced immunogenicity com-
pared to HES 130 [17]. Secondly, HES 130, but not
GEL, exerts its protective effects via a direct interac-
tion with the vascular endothelium and attenuates leu-
kocyte-endothelial cell interactions [39]. HES 130
dampens HS/R-induced acute neutrophil tissue accu-
mulation [15,40].
Figure 2 Tissue MDA concentrations following HS/R. Data are plotted as the means ± SD. *P <0.05 versus the sham group; &P < 0.05 versus
the HES 200 group; #P < 0.01 versus the GEL group. GEL, gelatin; HES, hydroxyethyl starch; HS/R, hemorrhagic shock/fluid resuscitation; MDA,
malondialdehyde.
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Figure 3 MPO levels in the liver, lungs, intestine and brain following HS/R in four groups. Data are plotted as the means ± SD. *P < 0.05
versus the sham group; &P < 0.05 versus the HES 200 group; #P < 0.01 versus the GEL group. GEL, gelatin; HES, hydroxyethyl starch; HS/R,
hemorrhagic shock/fluid resuscitation; MPO, myeloperoxidase.
Figure 4 Effects of different resuscitation fluids on HS/R-induced intestinal levels of TNF-a and IL-6. Data are plotted as the means ± SD.
*P < 0.05 versus the sham group; &P < 0.05 versus the HES 200 group; #P < 0.01 versus the GEL group. GEL, gelatin; HES, hydroxyethyl starch;
HS/R, hemorrhagic shock/fluid resuscitation.
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The gut is a critical organ that is damaged by HS/R.
The postischemic intestine releases proinflammatory
molecules, such as superoxide radicals and cytokines,
into the portal and systemic circulation, which produces
gut-induced remote organ failure [41]. Previous reports
have suggested a strong association between intestinal-
reperfusion injury and acute damage to the lungs or
liver [42-44]. An infusion of HES 130 in this study
inhibited the release of proinflammatory cytokines, such
as TNF-a and IL-6, which are responsible for gut bar-
rier dysfunction after HS/R [45,46]. This result suggests
a protective effect on gut barrier integrity, which
reduced the levels of oxidative stress and inflammatory
response in the liver, lungs and brain, and the occur-
rence of MOF. Additional studies on the long-term
effects of resuscitation fluids should clarify whether HES
130 can prevent MOF.
Despite the Advanced Trauma Life Support course
recommendations of lactated Ringer’s solution, a strong
case can be made for the use of colloids for initial resus-
citation in austere settings, such as battlefield care, in
which volume is necessarily limited. Actually, some col-
loid solutions have been recommended in the resuscita-
tion of hemorrhagic shock in Tactical Combat Casualty
Care [18,47,48].
The severity of HS was determined by bled volume
and BE in this experiment. BE is an expedient and sensi-
tive measure of both the degree and duration of hypo-
perfusion [49-51]. It could be a useful guide to volume
replacement in the resuscitation of trauma patients and
endpoints of resuscitation [52-54].
Our study has some limitations. The comparison results
were obtained based on a rat volume-controlled model,
which is modified to be more representative of traumatic
hemorrhage, and need to be verified in a clinical study.
Moreover, the maximal inflammatory and oxidative reac-
tion seems to occur within two hours post-resuscitation in
most studies [55,56]. The present study examined only a
single time point, that is, two hours after treatment. Thus,
further studies about the long-term effects of these colloid
solutions, especially the impact on organ function, are
needed.
Conclusions
The current experimental data indicate that resuscita-
tion after hemorrhagic shock with HES 130 attenuated
oxidative stress and the inflammatory response in tissues
following HS/R compared to HES 200 and GEL. No sig-
nificant differences in oxidative stress and the inflamma-
tory response were observed after 33 mL/kg HES 200
and GEL infusions. However, the efficacy of these col-
loids must be proved in the clinical arena. Therefore,
further randomized trials are required.
Key messages
• Infusions of HES 130/0.4, but not 200/0.5 or GEL,
significantly reduced MDA levels and MPO activity
in the liver, intestine, lungs and brain.
• Infusions of HES 130/0.4, but not HES 200/0.5 or
GEL, significantly inhibited the production of TNF-a
in the intestine two hours after resuscitation.
• No significant differences were observed after HES
200/0.5 or GEL administration at doses of approxi-
mately 33 mL/kg in a rat volume-controlled model.
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